MIRA INFORM REPORT

 

 

Report Date :

31.08.2014

 

IDENTIFICATION DETAILS

 

Name :

FARMASINO PHARMACEUTICALS (JIANGSU) CO., LTD.

 

 

Registered Office :

No. 100 Jianye Road, Nanjing, Jiangsu Province 210004 PR

 

 

Country :

China

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

17.10.2008

 

 

Com. Reg. No.:

320000000076867

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Subject includes permitted operation items: operating hazardous chemicals, non-medicine precursor chemicals, II & III class medical apparatus and instruments. General operation items: developing, researching and transferring chemical technology and information consultant and services; importing and exporting commodities and technology; selling chemical products; and domestic trade

 

 

No. of Employees

155

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 01, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

China

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

C2

Very High Risk

 

D

 


 

 

CHINA ECONOMIC OVERVIEW

 

Since the late 1970s China has moved from a closed, centrally planned system to a more market-oriented one that plays a major global role - in 2010 China became the world's largest exporter. Reforms began with the phasing out of collectivized agriculture, and expanded to include the gradual liberalization of prices, fiscal decentralization, increased autonomy for state enterprises, growth of the private sector, development of stock markets and a modern banking system, and opening to foreign trade and investment. China has implemented reforms in a gradualist fashion. In recent years, China has renewed its support for state-owned enterprises in sectors considered important to "economic security," explicitly looking to foster globally competitive industries. After keeping its currency tightly linked to the US dollar for years, in July 2005 China moved to an exchange rate system that references a basket of currencies. From mid 2005 to late 2008 cumulative appreciation of the renminbi against the US dollar was more than 20%, but the exchange rate remained virtually pegged to the dollar from the onset of the global financial crisis until June 2010, when Beijing allowed resumption of a gradual appreciation and expanded the daily trading band within which the RMB is permitted to fluctuate. The restructuring of the economy and resulting efficiency gains have contributed to a more than tenfold increase in GDP since 1978. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, China in 2013 stood as the second-largest economy in the world after the US, having surpassed Japan in 2001. The dollar values of China's agricultural and industrial output each exceed those of the US; China is second to the US in the value of services it produces. Still, per capita income is below the world average. The Chinese government faces numerous economic challenges, including: (a) reducing its high domestic savings rate and correspondingly low domestic consumption; (b) facilitating higher-wage job opportunities for the aspiring middle class, including rural migrants and increasing numbers of college graduates; (c) reducing corruption and other economic crimes; and (d) containing environmental damage and social strife related to the economy's rapid transformation. Economic development has progressed further in coastal provinces than in the interior, and by 2011 more than 250 million migrant workers and their dependents had relocated to urban areas to find work. One consequence of population control policy is that China is now one of the most rapidly aging countries in the world. Deterioration in the environment - notably air pollution, soil erosion, and the steady fall of the water table, especially in the North - is another long-term problem. China continues to lose arable land because of erosion and economic development. The Chinese government is seeking to add energy production capacity from sources other than coal and oil, focusing on nuclear and alternative energy development. Several factors are converging to slow China's growth, including debt overhang from its credit-fueled stimulus program, industrial overcapacity, inefficient allocation of capital by state-owned banks, and the slow recovery of China's trading partners. The government's 12th Five-Year Plan, adopted in March 2011 and reiterated at the Communist Party's "Third Plenum" meeting in November 2013, emphasizes continued economic reforms and the need to increase domestic consumption in order to make the economy less dependent in the future on fixed investments, exports, and heavy industry. However, China has made only marginal progress toward these rebalancing goals. The new government of President XI Jinping has signaled a greater willingness to undertake reforms that focus on China's long-term economic health, including giving the market a more decisive role in allocating resources

 

Source : CIA

 

 

 


Company name and address

 

FARMASINO PHARMACEUTICALS (JIANGSU) CO., LTD.

NO. 100 JIANYE ROAD, NANJING, JIANGSU PROVINCE 210004 PR CHINA

TEL: 86 (0) 25-84267953/86907288/86907282

FAX: 86 (0) 25-86907366

 

 

EXECUTIVE SUMMARY

 

DATE OF REGISTRATION          : OCTOBER 17, 2008

REGISTRATION NO.                  : 320000000076867

LEGAL FORM                           : LIMITED LIABILITY COMPANY

CHIEF EXECUTIVE                    : WAN HUIZHONG (LEGAL REPRESENTATIVE)

REGISTERED CAPITAL             : CNY 30,000,000

STAFF                                      : 155

BUSINESS CATEGORY             : TRADING

REVENUE                                : CNY 541,935,000 (AS OF DEC. 31, 2013)

EQUITIES                                 : CNY 50,707,000 (AS OF DEC. 31, 2013)

WEBSITE                                 : WWW.FARMASINO.COM

E-MAIL                                     : info@famasino.com

PAYMENT                                : AVERAGE

MARKET CONDITION                : COMPETITIVE

FINANCIAL CONDITION             : stable

OPERATIONAL TREND              : fairly STEADY

GENERAL REPUTATION           : AVERAGE

EXCHANGE RATE                     : CNY 6.15 = USD 1

 

 

 

Adopted abbreviations (as follows)

SC - Subject Company (the company inquired by you)

N/A – Not available

CNY – China Yuan Ren Min Bi


OPERATIONAL TREND & GENERAL REPUTATION

 

This section aims at indicating the relative positions of SC in respect of its operational trend & general reputation

 

Operational Trend:-                                             General Reputation:-

Upward                                                             Excellent

Steady                                                              Good

Fairly Steady                                                     Fairly Good

Ordinary                                                            Average

Fair                                                                   Fair

Stagnant                                                           Detrimental

Downward                                                         Not known

Not known                                                         Not yet be determined

Not yet be determined

 

 

LEGAL STATUS & HISTORY

 

SC was established as a limited liabilities company of PRC with State Administration of Industry & Commerce (SAIC) under registration No.: 320000000076867 on October 17, 2008.

 

SC’s Organization Code Certificate No.: 68114945-9

SC’s registered capital: CNY 30,000,000

 

SC’s paid-in capital: CNY 30,000,000

 

Registration Change Record:-

 

Date

Change of Contents

Before the change

After the change

--

Legal Representative

Fan Zhongfeng

Wan Huizhong

Shareholder’s Name

Jiangsu Light Industrial Products Import & Export (Group) Corporation

High Hope Zhongding Corporation

Registered Capital

CNY 10,000,000

CNY 30,000,000

% of shareholding

High Hope Zhongding Corporation

35%

Tong Xiao

5%

Wang Li

30%

Yan Libo

 30%

High Hope Zhongding Corporation

40%

Tong Xiao

5%

Wang Li 24.38%

Yan Libo

 30.62%

 

Current Co search indicates SC’s shareholders & chief executives are as follows:-

 

Name of Shareholder (s)

% of Shareholding

High Hope Zhongding Corporation

 

40

Tong Xiao

 

5

Wang Li

 

24.38

Yan Libo

 

30.62

 

SC’s Chief Executives:-

 

Position

Name

Legal Representative and Chairman

Wan Huizhong

General Manager

Yan Libo

Director

Fan Zhongfeng

Wang Li

Tong Xiao

Supervisor

Pan Shijie

 

RECENT DEVELOPMENT

 

No recent development was found during our checks at present.

 

 

SHAREHOLDER CHART & BACKGROUND

 

Name                                                  % of Shareholding

 

High Hope Zhongding Corporation                        40

 

Tong Xiao                                                          5

 

Wang Li                                                            24.38

 

Yan Libo                                                           30.62

 

 

High Hope Zhongding Corporation

=============================

High Hope Zhongding Corporation (formerly “Jiangsu Light Industrial Products Import & Export (Group) Corporation”) is one of the earliest foreign trade companies since the opening of Jiangsu port. Today the company has become a large-scale state enterprise with foreign trade as its leading work and a combination of real estate and investment business. Its registered capital is 278 million 592 thousand and 6 hundred Yuan. By the end of 2013, its net assets had exceeded 1 billion Yuan with annual business volume about 10 billion Yuan. The company mainly engages in export of light industrial products, textiles, machinery, ships, pharmaceuticals, chemicals, import and domestic trade of chemical materials, machinery and equipments. With an annual import and export volume over 1.2 billion USD, its business has spread over 100 countries and regions. For many years, it has ranked among the first hundred of five hundred enterprises holding the largest import and export amount in China. The brands of “FRIENDLY” and “JSLTOYS” have been recognized by the state as specially supported key brands for export and “Panda”, “Tiger”, “Swallow” as Jiangsu provincial famous brands.

 

Date of Registration: October 15, 1981

Registration No.: 320000000000640

Chief Executive: Wan Huizhong

Registered Capital: CNY 278,592,600

Tel: 86-25-58006166 

Fax: 86-25-84208398

Web: www.jslgroup.com

E-mail: jsl@jslgroup.com

 

 

MANAGEMENT

 

Wan Huizhong , Legal Representative and Chairman

-------------------------------------------------------------------------------

Gender: M

Age: 50

Qualification: University

Working experience (s):

 

At present, working in SC as chairman and legal representative

Also working in High Hope Zhongding Corporation, Jiangsu Kaiyuan International Machinery Co., Ltd., Jiangsu Kaiyuan Tourism Co., Ltd., Jiangsu Kaiyuan International Tianpu Tools Co., Ltd., Jiangsu Zhongxin Toys Co., Ltd., Nanjing Kaiyuan Kangda Trading Co., Ltd., etc. as legal representative

 

 

Yan Libo , General Manager

------------------------------------------------

Gender: M

Age: 38

Qualification: University

Working experience (s):

 

From 2008 to present, working in SC as general manager and director

Also working in FarmaSino Pharmaceuticals (Anhui) Co., Ltd. as legal representative

 

 

Director

-----------

Fan Zhongfeng

Wang Li

Tong Xiao

 

 

Supervisor

--------------

Pan Shijie

 

 

BUSINESS OPERATION

 

SC’s registered business scope includes permitted operation items: operating hazardous chemicals, non-medicine precursor chemicals, II & III class medical apparatus and instruments. General operation items: developing, researching and transferring chemical technology and information consultant and services; importing and exporting commodities and technology; selling chemical products; and domestic trade.

 

SC is mainly engaged in trading of pharmaceuticals, chemicals, etc.

 

Brand: FARMASINO

 

SC’s products mainly include:

Finished Drugs (Tablets, Capsules, Liquid Injections, Powder for Injections, Miscellaneous, Packing Materials, Surgicals, Animal Medicine) 

Bulk Pharmaceuticals (Active Pharmaceutical Ingredients, Veterinary Products, Amino Acids, Vitamins, Plant Extracts, Nutritional Supplements, Food Additives)

Intermediates & Chemicals (Pharmaceutical Intermediates, Agrochemical Intermediates, Pigment Intermediates, Fine Chemicals, Petrochemicals, Customer Manufacturing)

 

SC sources its materials 100% from domestic market. SC sells 40% of its products in domestic market, and 60% to overseas market, mainly European and Indian market.

 

The buying terms of SC include Check, T/T and Credit of 30-60 days. The payment terms of SC include Check, T/T, L/C and Credit of 30-60 days.

 

*Major Customers:

==============

Catherych Inc.

Utc Overseas Inc.

Gurvey & Berry Co. Inc.

 

Staff & Office:

--------------------------

SC is known to have approx. 155 staff at present.

 

SC owns an area as its operating office and factory, but the detailed information is unknown.

 

 

RELATED COMPANY

 

Jiangsu Kaiyuan International Machinery Co., Ltd.

 

Jiangsu Kaiyuan Tourism Co., Ltd.

 

Jiangsu Kaiyuan International Tianpu Tools Co., Ltd.

 

Jiangsu Zhongxin Toys Co., Ltd.

 

Nanjing Kaiyuan Kangda Trading Co., Ltd.

 

Etc.

 

 

SC is known to have a subsidiary at present,

 

FarmaSino Pharmaceuticals (Anhui) Co., Ltd.

------------------------------------

Date of Registration: October 15, 2008

Registration No.: 341424000008410

Chief Executive: Yan Lipo

Registered Capital: CNY 5,000,000

 

 

PAYMENT

 

Overall payment appraisal:

( ) Excellent      ( ) Good      (X) Average      ( ) Fair      ( ) Poor      ( ) Not yet be determined

The appraisal serves as a reference to reveal SC's payments habits and ability to pay.  It is based on the 3 weighed factors: Trade payment experience (through current enquiry with SC's suppliers), our delinquent payment and our debt collection record concerning SC.

 

Trade payment experience: SC did not provide any name of trade/service suppliers and we have no other sources to conduct the enquiry at present.

 

Delinquent payment record: None in our database.

 

Debt collection record: No overdue amount owed by SC was placed to us for collection within the last 6 years.

 

 

BANKING

 

Basic Bank:

 

Bank of China Jiangsu Branch

 

AC#: 509258191251

 

 

FINANCIALS

 

Balance Sheet

Unit: CNY’000

As of Dec. 31, 2012

As of Dec. 31, 2013

Cash

85,442

87,564

Notes receivable

0

0

Accounts receivable

54,382

83,349

Advances to suppliers

26,788

31,502

Other receivable

413

18,464

Inventory

10,110

14,588

Non-current assets within one year

0

0

Other current assets

9,645

14,005

 

------------------

------------------

Current assets

186,780

249,472

Fixed assets

1,228

17,107

Construction in progress

0

0

Intangible assets

0

0

Long-term prepaid expenses

0

1,189

Deferred income tax assets

87

104

Other non-current assets

0

8,041

 

------------------

------------------

Total assets

188,095

275,913

 

=============

=============

Short-term loans

48,000

35,000

Notes payable

76,639

130,254

Accounts payable

33,759

38,402

Wages payable

0

0

Taxes payable

-414

-1,092

Advances from clients

5,397

22,431

Other payable

140

211

Other current liabilities

0

0

 

------------------

------------------

Current liabilities

163,521

225,206

Non-current liabilities

0

0

 

------------------

------------------

Total liabilities

163,521

225,206

Equities

24,574

50,707

 

------------------

------------------

Total liabilities & equities

188,095

275,913

 

=============

=============

 

Income Statement

Unit: CNY’000

As of Dec. 31, 2012

As of Dec. 31, 2013

Revenue

500,282

541,935

     Cost of sales

472,186

510,793

     Sales expense

18,966

21,579

     Management expense

2,024

3,685

     Finance expense

650

-2,608

Non-business income

63

174

     Non-business expenditure

315

366

Profit before tax

6,194

8,226

Less: profit tax

1,670

2,093

Profits

4,524

6,133

 

Important Ratios

=============

 

As of Dec. 31, 2012

As of Dec. 31, 2013

*Current ratio

1.14

1.11

*Quick ratio

1.08

1.04

*Liabilities to assets

0.87

0.82

*Net profit margin (%)

0.90

1.13

*Return on total assets (%)

2.41

2.22

*Inventory / Revenue ×365

8 days

10 days

*Accounts receivable/ Revenue ×365

40 days

57 days

*Revenue/Total assets

2.66

1.96

*Cost of sales / Revenue

0.94

0.94

 

 

FINANCIAL COMMENTS

 

PROFITABILITY: AVERAGE

The revenue of SC appears fairly good in its line.

SC’s net profit margin is average.

SC’s return on total assets is average.

SC’s cost of sales is fairly high, comparing with its revenue.

 

LIQUIDITY: AVERAGE

The current ratio of SC is maintained in a normal level.

SC’s quick ratio is maintained in a fairly good level.

The inventory of SC is maintained in an average level.

The accounts receivable of SC is maintained in an average level.

SC’s short-term loans are in an average level.

SC’s revenue is in an average level, comparing with the size of its total assets.

 

LEVERAGE: AVERAGE

The debt ratio of SC is average.

The risk for SC to go bankrupt is average.

 

Overall financial condition of the SC: Stable.

 

 

CONCLUSIONS

 

SC is considered large-sized in its line with stable financial conditions.

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.47

UK Pound

1

Rs.100.35

Euro

1

Rs.79.86

 

INFORMATION DETAILS

 

Report Prepared by :

TPT

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.